1 / 12

Global tissue engineered medical devices market forecast and opportunities, 2020

Pharmaion offers latest market research report for "Global tissue engineered medical devices" that show the global tissue engineered medical devices market is anticipated to surpass US$ 26 billion by 2020.<br>

Pharmaion
Download Presentation

Global tissue engineered medical devices market forecast and opportunities, 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. India Adhesives Market Forecast & Opportunities, 2020 Forecast & Opportunities, 2020 Global Tissue Engineered Medical Devices Market P h a r m a & H e a l t h c a r e C o n s u l t a n t s

  2. I n d u s t r y B r i e f Global tissue engineered medical devices market is anticipated to cross US$ 26 billion by 2020 Increasing aging population, rising number of diabetic patients and various ongoing innovations to drive the global tissue engineered medical devices market According to recently published Pharmaion report, “Global Tissue Engineered Medical Devices Market Forecast And opportunities, 2020”, global tissue engineered medical devices market is anticipated to cross US$ 26 billion by 2020. A wide array of factors that are expected to positively influence the global tissue engineered medical devices market during forecast period include increasing aging population, ongoing technological advancements and growing consumer awareness. Moreover, as compared to artificial implants, tissue engineered implants offer better biocompatibility, thereby minimizing the probability of rejection of implant from the body. Global tissue engineered medical devices market is also driven by the increasing prevalence diabetes and associated diseases across the globe. Diabetes carries a high risk of cardiovascular diseases and neuropathy. Neuropathy is among the root causes of foot amputations and ulcers in the diabetic patient, and treatment process in this case requires skin substitutes. Rising prevalence of diabetes and resulting increase in foot ulcers is expected to be one of the major factors responsible for the rapid growth of skin substitutes during the forecast period. New product launches by existing market players as well as new entrants is expected to boost the global tissue engineered medical devices market during forecast period. North America dominated the global tissue engineered medical devices market in 2014, and is anticipated to continue its dominance through 2020 as the percentage of geriatric population is very high in this region. Moreover, the economic stability of the region also helps patients to undergo expensive treatment options. “Global tissue engineered medical devices market will continue to exhibit growth during the next five years. Growing adoption of nanotechnology and 3D Bioprinting, rising application of engineered protein, and escalating applications of stem cells are among the major factors driving global tissue engineered medical devices market. The demand of skin substitutes is increasing at a significant pace on account of rising neuropathy cases among diabetics and improving efficacy of skin substitute products.” said Mr. Karan Chechi, Research Director with Pharmaion, a research based global pharmaceutical and healthcare consulting firm. 2 © Pharmaion

  3. Ta b l e o f C o n te n t s S. No. Contents 1. Research Methodology 2. Analyst View 3. Tissue Engineering Overview 4. Global Tissue Engineered Medical Devices Market Outlook 4.1. Market Size & Forecast 4.1.1. By Value 4.1.2. By Volume 4.2. Market Share & Forecast 4.2.1. By Application 4.2.2. By Source 4.2.3. By Region 4.2.4. By Company 4.3. Quality Control Policies 5. Global Tissue Engineered Medical Devices Segmental Market Outlook 5.1. Global Orthopedic Tissue Engineered Medical Devices Market Outlook 5.1.1. Market Size & Forecast 5.1.1.1. By Value 5.1.1.2. By Volume 5.1.2. Market Share & Forecast 5.1.2.1. By Product Type 5.1.2.2. By Region 3 5.1.2.3. By Company 5.2. Global Cardiac Tissue Engineered Medical Devices Market Outlook © Pharmaion

  4. Ta b l e o f C o n te n t s S. No. Contents 5.2.1. Market Share & Forecast 5.2.1.1. By Value 5.2.1.2. By Volume 5.2.2. Market Share & Forecast 5.2.2.1. By Product Type 5.2.2.2. By Region 5.2.2.3. By Company 5.3. Global Dental Tissue Engineered Medical Devices Market Outlook 5.3.1. Market Size & Forecast 5.3.1.1. By Value 5.3.1.2. By Volume 5.3.2. Market Share & Forecast 5.3.2.1. By Product Type 5.3.2.2. By Region 5.3.2.3. By Company 5.4. Global Skin Substitutes Engineered Medical Devices Market Outlook 5.4.1. Market Size & Forecast 5.4.1.1. By Value 5.4.1.2. By Volume 5.4.2. Market Share & Forecast 5.4.2.1. By Application 4 5.4.2.2. By Region 5.4.2.3. By Company © Pharmaion

  5. Ta b l e o f C o n te n t s S. No. Contents 6. Global Tissue Engineered Medical Devices Regional Market Outlook 6.1. North America Tissue Engineered Medical Devices Market Outlook 6.1.1. Market Size & Forecast 6.1.1.1. By Value 6.1.2. Market Share & Forecast 6.1.2.1. By Country 6.1.2.2. By Application 6.2. Europe Tissue Engineered Medical Devices Market Outlook 6.2.1. Market Size & Forecast 6.2.1.1. By Value 6.2.2. Market Share & Forecast 6.2.2.1. By Country 6.2.2.2. By Application 6.3. South America Tissue Engineered Medical Devices Market Outlook 6.3.1. Market Size & Forecast 6.3.1.1. By Value 6.3.2. Market Share & Forecast 6.3.2.1. By Country 5 6.3.2.2. By Application © Pharmaion

  6. Ta b l e o f C o n te n t s S. No. Contents 6.4. Asia-Pacific Tissue Engineered Medical Devices Market Outlook 6.4.1. Market Size & Forecast 6.4.1.1. By Value 6.4.2. Market Share & Forecast 6.4.2.1. By Country 6.4.2.2. By Application 6.5. Middle East & Africa Tissue Engineered Medical Devices Market Outlook 6.5.1. Market Size & Forecast 6.5.1.1. By Value 6.5.2. Market Share & Forecast 6.5.2.1. By Country 6.5.2.2. By Application 7. Market Dynamics 7.1. Drivers 7.2. Challenges 8. Market Trends & Developments 8.1. Nanotechnology in Tissue Engineering 8.2. 3D Bioprinting Advancing the Tissue Engineering 8.3. Bone Tissue Engineering Witnessing Continuous Innovation 8.4. Increasing Use of Tissue Engineered for Chronic Wound Healing 6 Rising Application of Engineered Protein in Tissue Engineering 8.5. © Pharmaion

  7. Ta b l e o f C o n te n t s S. No. Contents 8.6. Tissue Engineering and Biomaterials will Revolutionize Plastic Surgery Industry 8.7. Tissue Engineering: Future of Ophthalmology 8.8. Escalating Use of Stem Cells in Tissue Engineering Research 9. Competitive Landscape 9.1. Competition Benchmarking 9.2. Company Profiles 9.2.1. Medtronic plc 9.2.2. Stryker Corporation 9.2.3. Zimmer Biomet 9.2.4. DePuy Synthes 9.2.5. Edwards Lifesciences Corporation 9.2.6. Smith & Nephew 9.2.7. Geistlich Pharma AG 9.2.8. Organogenesis Inc. 9.2.9. Institut Straumann AG 9.2.10. CryoLife, Inc. 9.2.11. Dentsply International 9.2.12. Integra LifeSciences Corporation 9.2.13. MiMedx Group, Inc. 9.2.14. St. Jude Medical, Inc. 9.2.15. B. Braun Melsungen AG 7 9.2.16. Wright Medical Technology, Inc. © Pharmaion

  8. Ta b l e o f C o n te n t s S. No. Contents 9.2.17. ACE Surgical Supply Company, Inc. 9.2.18. BioHorizons IPH, Inc. 9.2.19. Botiss Biomaterials GmbH 9.2.20. Cytograft Tissue Engineering 9.2.21. Mölnlycke Health Care 9.2.22. TEI Biosciences 10. Strategic Recommendations 11. About Us & Disclaimer 8 © Pharmaion

  9. Re s e a rc h M e t h o d o l o g y Baseline Methodology : For the study, Pharmaion has gathered information through primary research with respondents in tissue engineered medical devices market across the globe, followed by external validation of the information by interviewing the users. We also gathered insights through an exhaustive search of credible paid databases and our internal database. Our team of analysts has prudently evaluated all the collected information and presented the same in chronological order to depict a meaningful and clear picture of tissue engineered medical devices in all the regions across the world. While compiling the data, we have also validated all the collected information from multiple sources and data warehouses, in order to present the most accurate and precise information of the concerned industry. The information has then been verified through primary research surveys with competitors to arrive at logical figures. Companies Interviewed SRI Research, Medtronic Inc., DePuy Synthes, Cryolife, Inc., Wright Medical Technology, Smith & Nephew, Ferentis Sources : Company Websites, Company Annual Reports, Government Database (American Academy of Orthopedic Surgeons, Centers for Disease Control and Prevention, CORDIS, etc.), WHO Reports 9 © Pharmaion

  10. S a m p l e D a t a - S n a p s h o t Global Tissue Engineered Medical Devices Market United States Prevalence of United States Percentage Breakdown Share, By Source, By Value, 2010-2020F Cardiovascular Disease in Adults above of Deaths due to Cardiovascular 60.00% 60.10% 60.20% 60.30% 60.40% 60.50% 60.60% 60.70% 60.80% 60.90% 61.00% 20 years of Age, By Age, By Sex, 2015 Disease, 2011 (% of total population) Coronary Heart Disease, 10.00% Others, 10.00% 9 7 35.00% 35.10% 35.20% 35.30% 35.40% 35.50% 35.60% 35.70% 35.80% 35.90% 36.00% Diseases of Arteries, 10.00% 5 4 3 3 Stroke, 10.00% 2 1 Heart Failure, 10.00% 2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F High Blood Pressure, 10.00% Synthetic Biomaterials Natural Biomaterials 20-39 40-59 60-79 80+ Global Tissue Engineered Medical Devices Market Share, By Men Women North America Tissue Engineered Medical Company, By Value, 2014 & 2020F Devices Market Size, By Value (USD United States Demand for Medtronic plc, 15.00% Billion), 2010-2020F 12 Others, 25.00% Kidney Donor, 1990 & 2012 11 Medtronic plc, 10.00% 10 Others, 10.00% 9 8 7 Kidney Transp lant Opera tions Stryker Corporati on, 15.00% 5 4 3 2 10000 1 Edwards Lifesciences Corporation, 10.00% Stryker Corporation, 10.00% Edwards Lifescienc es Corporati on, 15.00% 2020F 2014 1000 16,485 Zimmer Biomet, 15.00% 12,000 1990 Depuy Synthes, 15.00% Zimmer Biomet, 10.00% 2012 Depuy Synthes, 10.00% Global Tissue Engineered Medical Devices Market Share, By Application, By Value, 2010-2020F Global Tissue Engineered Medical Devices 55.90% 56.00% 55.80% 55.70% 55.60% 55.50% 55.40% 55.30% 55.20% 55.10% 55.00% Market Size, By Value (USD Billion), By Volume (Million Units), 2010-2020F 25 23 21 19 17 15.00% 14.90% 14.80% 14.70% 14.60% 14.50% 14.40% 14.30% 14.20% 14.10% 15 12 14.00% 11 7.00% 6.90% 6.80% 6.70% 6.60% 6.50% 6.40% 11 6.30% 6.20% 10 6.10% 6.00% 9 9 8 7 7 5 5 4 3 3 4.00% 3.90% 3.80% 3.70% 3.60% 3.50% 3.40% 3.30% 3.20% 3.10% 3.00% 2 1 10 18.00% 17.90% 17.80% 17.70% 17.60% 17.50% 17.40% 17.30% 17.20% 17.10% 17.00% 2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F 2010 2011 2012 Others 2013 2014 Skin Substitute 2015E 2016F 2017F 2018F 2019F 2020F © Pharmaion Dental Value (USD Billion) Volume (Million Units)

  11. Re p o r t O rd e r i n g Report Name: Global Tissue Engineered Medical Devices Market Forecast and Opportunities, 2020 Report Price License Type Price Single User License $4000 Single User License Print $4500 Enterprise License $8000 To View Sample OR Purchase Report 11 © Pharmaion

  12. A b o u t U s & D i s c l a i m e r About Us Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry. Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound by legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients. Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them with comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consulting requirements. Related Reports India Stem Cells Market Forecast & Opportunities, 2020 India Infertility Treatment Market Forecast & Opportunities, 2020 Global Cervical Cancer Vaccine Market Forecast & Opportunities, 2020 Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants. NORTH AMERICA Pharmaion Consultants LLC 708 3RD Avenue, 6th Floor, New York, NY, United State, 10017 sales@pharmaion.com +1 646 360 1656 www.pharmaion.com ASIA PACIFIC Pharmaion Consultants Pvt. Ltd. A – 51, Sector 57, Noida, National Capital Region, India - 201301 sales@pharmaion.com +91 - 120 - 452 3900 www.pharmaion.com 12 © Pharmaion

More Related